Choose Injectable Delivery When: Maximum bioavailability and systemic distribution are required Your peptide has a molecular weight exceeding 6,000 Da Precise dosing and reproducible pharmacokinetics are necessary Youre using peptides for bodybuilding or muscle growth The peptide lacks CNS targets Choose Nasal Delivery When: Direct CNS delivery and blood-brain barrier bypass are therapeutic objectives Your peptide is small (under 6,000 Da) and shows adequate nasal bioavailability Rapid onset of action (minutes) is clinically valuable Patient compliance and comfort are primary concerns Youre using neurological peptides like Semax or Selank The FDA has approved several intranasal peptide formulations, including ZAVZPRET for acute migraine treatment, validating this delivery route as pharmaceutically viable

Risk factors include underlying renal insufficiency, intravascular volume depletion (sometimes seen in people on strong diuretics, as well as those with poor oral fluid intake, gastroenteritis, or chronic diarrhea), diabetes, heart failure, being 60 years of age or older, exposure to multiple nephrotoxins, etc
For healthy mucus protection (Table 2), trials involving ethyl lauroyl arginate hydrochloride (LAEH) (NCT05768113, LAEH for COVID-19) and povidone-iodine sprays have largely remained exploratory, with relatively small trial sizes
doi: 10.1016/j.ebiom.2020.102879 110 ZhangYLiQRaoESunYGrossmannMEMorrisRJet al
Epithalon and Skin Health Studies have shown that Epithalon may influence fibroblast activity, enhance collagen synthesis, and reduce oxidative damage in skin tissue